Immunomorphology and Morphogenesis of Affected Skin Foci at Psoriasis


Cite item

Abstract

The article provides information about the pathogenic role of different immunocompetent cells in forming an immune inflammation in the skin of psoriasis patients, which is one of the most important factors in the development of psoriatic eruptions in case of exacerbation of the disease. The contents of CD4+ helper lymphocytes, CD8+ suppressor/cytotoxic lymphocytes, CD1a+ Langerhans cells and HLA-DR+ cells in the affected skin in psoriasis patients were analyzed. It was revealed that the development of an immune inflammation in the skin of psoriasis patients involves cells of congenital (CD1a+ Langerhans cells) and adaptive immunity (CD4+ and CD8+ Т lymphocytes), and their number grows.

About the authors

A A KUBANOVA

O R KATUNINA

References

  1. Клиническая дерматовенерология / Под ред. Ю.К. Скрипкина, Ю.С. Бутова. - Москва: ГЭОТАР-Медиа, 2009. - T.II, гл. 8. С. 212-33.
  2. Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370:9583:263-271.
  3. Lee M.R., Cooper A.J. Immunopathogenesis of psoriasis. Australas Journal of Dermatology 2006; 47:3:151-159.
  4. Liu Y., Krueger J.G. Psoriasis: genetic associations and immune system changes. Genes. Immunology 2007: 8:1:1-12.
  5. Nickoloff B.J., Schröder J.M., von den Driesch P. et al. Is psoriasis a T-cell disease? Experimental Dermatology 2000: 9:5:359-375.
  6. Gudjonsson J.E., Johnston A., Sigmundspottir H.et al. Immunopathogenetic mechanisms in psoriasis. Clinical Experimental Immunology 2004; 135: 1-8.
  7. Sabat R., Philipp S., Höflich C. et al. Immunopathogenesis of psoriasis. Experimental Dermatology 2007; 16:10:779-798.
  8. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts andspeculations. Immunology Today 1999; 20:40-46.
  9. Nickoloff B.J., Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. Journal of Clinical Investigative 2004; 113:12: 1664-1675.
  10. Campalani E., Barker J.N. The Clinical Genetics of Psoriasis. Current Genomics 2005; 6: 51-60.
  11. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature; 2007:445:866-873.
  12. Грибова А.А.Патогенетическая терапия тяжелых форм псориаза ремикейдом и тимогеном: Автореферат дисс... канд. мед. наук. Москва, 2004.
  13. Охлопков В.А. Оценка тяжести вульгарного псориаза. Клиническая дерматология и венерология, 2004; 2: 67-70.
  14. Пинсон И.Я., Довжанский С.И., Берщанская А.М. и др. К вопросу о патогенезе псориаза. Российский журнал кожных и венерических болезней, 2006; 2: 24-27.
  15. Лифшиц Е.Г. Патоморфологические особенности кожи при различных формах псориаза. Российский журнал кожных и венерических болезней, 2006; 5: 35-36.
  16. Скрипкин Ю.К., Лезвинская Е.М. Кожа - орган иммунной системы. Вестник дерматологии и венерологии, 1989;10:14-18.
  17. Персина И.С. Иммунная система кожи в норме и патологии // Патология кожи / под ред. В.Н. Мордовцева и Г.М. Цветковой - Москва: Медицина, 1993. Т. 1. С. 162-213.
  18. Вавилов А.М., Лезвинская Е.М. Иммунокомпетентные структуры кожи и их роль в развитии первичных кожных лимфом. Архив патологии, 1996; 6:7-12.
  19. Ярилин А.А. Кожа и иммунная система // Эстетическая медицина, 2003; 2: 2: 112-121.
  20. Debenedictis C., Jouben S., Zhang G. et al. Immune function of the skin. Clinics in Dermatology 2001; 19: 573-585.
  21. dark R.A. et al. The vast majority of CLA+ T cells are resident in normal skin. Journal of Immunolology 2006; 176: 4431-4439.
  22. Streinlein J.W. Skin-associated lymphoid tissue (SALT): original and functions. Journal of Investigative Dermatology 1983; 80:12.
  23. Кокряков В.Н. Очерки о врождённом иммунитете. - Санкт-Петербург: Наука, 2006: 261.
  24. Абелев Г.И. Взаимодействие врожденного и приобретенного иммунитета в защите организма от инфекции. Соросовский образовательный журнал, 1998; 2: 53-58.
  25. Cooper M.D., Alder M.N. The evolution of adaptive immune systems. Cell 2006;124:4:815-822.
  26. Voorhees J.J. Pathophysiology of psoriasis. Annu. Rev. Med. 1977; 28:467-473.
  27. Barker J N. Psoriasis as a T cell-mediated autoimmune disease . Hosp. Med. 1998; 59:530-533.
  28. Medzhitov, R., Janeway Jr., C.A. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 1997; 9: 4-9.
  29. Janeway C.A., Travers P., Walport M.et al. Immunobiology. 6th Ed., Garland Science Publishing, 2004; 89-91.
  30. Быкова В.П., Калинин Д.В. Иммунный барьер слизистых оболочек в современном прочтении. Российская ринология, 2009; 1:40-43.
  31. Kupper T.S.,Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nature reviews 2004; 4: 211-222.
  32. Lever's histopathology of the skin. - 9th ed./ editor-in-chief David E. Elder. 2004.
  33. Персина И.С. Клетки Лангерганса - структура, функция, роль в патологии. Архив патологии, 1985; 2: 86-93.
  34. Murthy V.L., Stern L.J. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide bindidng. Structure 1997; 5:10: 1385-1396.
  35. Bos J.D., Hulsebosh H.J., Krieg S.R. et al Immunocompetent cells in psoriasis. In site immunophenotiyping by monoclonal antibodies. Arch. Dermatol. Res. 1983; 275: 181-189.
  36. Baker B.S., Swain A.F., Fry L. et al. Epidermal T-lymphocites and HLA-DR expression in psoriasis. British Journal of Dermatology 1984; 110:555-564.
  37. Mueller W., Herrmann B. Cyclosporin A for psoriasis. New England Journal of Medicine 1979; 301: 555.
  38. Nicolas J.F., Chamchick N., Thivolet J. et al. CD4 antibody treatment of severe psoriasis. Lancet 1991; 338:321.
  39. Nickoloff B.J., Wrone-Smith T. Injection of pre-psoriatic skin with СD4+ T cells induces psoriasis. American Journal of Pathology 1999; 155: 145-158.
  40. Eedy D.J., Burrowa D., Bridges D. et al. Clearance of severe psoriasis after allogenic bone marrow transplantation. British Medical Journal 1990; 300: 908.
  41. Gardembas-Pain M., Ifrah N., Foussard C. et al. Psoriasis after allogeneic bone marrow transplantation. Archives of Dermatology 1990; 126: 1523.
  42. Haftek M., Faure M., Schmitt D. et al. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. Journal of Investative Dermatology 1983; 81:10-14.
  43. Deguchi M., Aiba S., Ohtani H. et al. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease. Archives of Dermatology 2002; 294:297-302.
  44. Zhang M., Zhang Y.Z., Wang S. et al. Dendritic cells, natural killer cells and adhesion molecules in psoriasis. Sichuan Da Xue Xue Bao Yi Xue Ban 2004; 5: 626-629.
  45. Gilleaudeau P., Sullivan-Whalen M., Wittkowski K.M. et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalisumam (anti-CD11a). Proc. Nat. Acad. Sci. USA 2005; 102:19057-19062.
  46. Gottlieb A.B., Lifshitz B., Fu S.M. et al. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. Journal of Experimental Medicine 1986; 164: 1013-1028.
  47. Гуревич Л.Е., Исаков В.А. Использование в иммуногистохимических исследованиях метода восстановления антигенной специфичности воздействием микроволн на ткани, фиксированные формалином и заключенные в парафин. Архив патологии, 1999; 2: 48-50.

Copyright (c) 2010 KUBANOVA A.A., KATUNINA O.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies